77 related articles for article (PubMed ID: 26267133)
1. Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assay.
Haaß W; Kleiner H; Müller MC; Hofmann WK; Fabarius A; Seifarth W
PLoS One; 2015; 10(8):e0133769. PubMed ID: 26267133
[TBL] [Abstract][Full Text] [Related]
2. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
Haaß W; Kleiner H; Weiß C; Haferlach C; Schlegelberger B; Müller MC; Hehlmann R; Hofmann WK; Fabarius A; Seifarth W; ;
PLoS One; 2015; 10(6):e0129648. PubMed ID: 26087013
[TBL] [Abstract][Full Text] [Related]
3. Separase activity distribution can be a marker of major molecular response and proliferation of CD34
Spiess B; Kleiner H; Flach J; Fabarius A; Saussele S; Hofmann WK; Seifarth W
Ann Hematol; 2020 May; 99(5):991-1006. PubMed ID: 32253454
[TBL] [Abstract][Full Text] [Related]
4. Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS.
Ruppenthal S; Kleiner H; Nolte F; Fabarius A; Hofmann WK; Nowak D; Seifarth W
PLoS One; 2018; 13(1):e0191734. PubMed ID: 29370237
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a fluorogenic assay to measure separase enzyme activity.
Basu D; Zhang N; Panigrahi AK; Horton TM; Pati D
Anal Biochem; 2009 Sep; 392(2):133-8. PubMed ID: 19497291
[TBL] [Abstract][Full Text] [Related]
6. c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia.
Prinzhorn W; Stehle M; Kleiner H; Ruppenthal S; Müller MC; Hofmann WK; Fabarius A; Seifarth W
Biomark Res; 2016; 4():5. PubMed ID: 26937281
[TBL] [Abstract][Full Text] [Related]
7. Proteasome proteolytic activity in hematopoietic cells from patients with chronic myeloid leukemia and multiple myeloma.
Magill L; Lynas J; Morris TC; Walker B; Irvine AE
Haematologica; 2004 Dec; 89(12):1428-33. PubMed ID: 15590391
[TBL] [Abstract][Full Text] [Related]
8. Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice.
Mukherjee M; Ge G; Zhang N; Huang E; Nakamura LV; Minor M; Fofanov V; Rao PH; Herron A; Pati D
PLoS One; 2011; 6(7):e22167. PubMed ID: 21799785
[TBL] [Abstract][Full Text] [Related]
9. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
10. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X; Saw KM; Eaves A; Eaves C
J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
[TBL] [Abstract][Full Text] [Related]
11. Human chromosome segregation involves multi-layered regulation of separase by the peptidyl-prolyl-isomerase Pin1.
Hellmuth S; Rata S; Brown A; Heidmann S; Novak B; Stemmann O
Mol Cell; 2015 May; 58(3):495-506. PubMed ID: 25921067
[TBL] [Abstract][Full Text] [Related]
12. Biology and insights into the role of cohesin protease separase in human malignancies.
Zhang N; Pati D
Biol Rev Camb Philos Soc; 2017 Nov; 92(4):2070-2083. PubMed ID: 28177203
[TBL] [Abstract][Full Text] [Related]
13. Centrosome reduction in newly-generated tetraploid cancer cells obtained by separase depletion.
Galofré C; Asensio E; Ubach M; Torres IM; Quintanilla I; Castells A; Camps J
Sci Rep; 2020 Jun; 10(1):9152. PubMed ID: 32499568
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
15. Reconsideration of BCR-ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?
Kelani R; Monem F
Int J Lab Hematol; 2015 Oct; 37(5):723-8. PubMed ID: 26059167
[TBL] [Abstract][Full Text] [Related]
16. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.
Raimondo S; Saieva L; Corrado C; Fontana S; Flugy A; Rizzo A; De Leo G; Alessandro R
Cell Commun Signal; 2015 Feb; 13():8. PubMed ID: 25644060
[TBL] [Abstract][Full Text] [Related]
17. Proteasome proteolytic profile is linked to Bcr-Abl expression.
Crawford LJ; Windrum P; Magill L; Melo JV; McCallum L; McMullin MF; Ovaa H; Walker B; Irvine AE
Exp Hematol; 2009 Mar; 37(3):357-66. PubMed ID: 19157685
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker.
Sun X; Li J; Chen J; Li D; Chen L; Xu W; Yang Y; Wu Y; Jiang P; Xie W
Ann Hematol; 2009 Jan; 88(1):29-36. PubMed ID: 18696070
[TBL] [Abstract][Full Text] [Related]
19. Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr-Abl-positive cells.
Desplat V; Lagarde V; Belloc F; Chollet C; Leguay T; Pasquet JM; Praloran V; Mahon FX
Cytometry A; 2004 Nov; 62(1):35-45. PubMed ID: 15468123
[TBL] [Abstract][Full Text] [Related]
20. Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy.
Zhang N; Scorsone K; Ge G; Kaffes CC; Dobrolecki LE; Mukherjee M; Lewis MT; Berg S; Stephan CC; Pati D
J Biomol Screen; 2014 Jul; 19(6):878-89. PubMed ID: 24525869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
